AI Psychiatry Software Raises €1.7M for Growth

Copenhagen-based Aisel Health has successfully closed a €1.7 million pre-Seed funding round, signaling a significant step forward in its mission to revolutionize psychiatric care through advanced AI. The investment, led by Caesar Ventures, with crucial participation from Nordic Web Ventures, LifeX, and Angel Invest, alongside existing backers Rockstart and EIFO, will fuel the company's expansion and product development.

Aisel Health is developing a specialized operating system designed to address the unique challenges within psychiatric and mental health services. Co-founder and CEO Augusta Klingsten Peytz emphasized the need for technology tailored to the nuanced realities of psychiatric practice, stating, "Psychiatry doesn’t need more generic technology bolted onto an already overburdened workflow. It needs a product built around the realities of psychiatric care – where clinicians bring judgment, empathy, and years of trained intuition, and the technology brings the speed, structure, and ability to hold together every detail about every patient, in a way no human memory can."

The company's platform aims to enhance operational efficiency for psychiatric clinics by intelligently surfacing critical patient information for clinicians precisely when it's needed. This approach is designed not only to improve the patient experience and alleviate staff workload but also to boost clinic profitability. Aisel Health's research, including their "The Documentation Minute" study, highlights a critical bottleneck: psychiatrists spend a disproportionate amount of time gathering patient history from disparate sources rather than direct patient interaction or note-taking.

Co-founder and CPO Christian Houen elaborated on the limitations of current AI solutions, noting, "AI scribes work – they write notes faster, and that’s great for immediate burnout. But that’s not what’s keeping waiting lists long. Make notes cheaper to produce, and you just make that information harder to find when a clinician needs it." Aisel Health's solution tackles this by transforming raw data, interview recordings, and patient accounts into structured, contextual insights, providing clinicians with immediate access to relevant patient history and context before, during, and after consultations.

The mental health technology sector is experiencing substantial growth, driven by increasing awareness of mental well-being and the strain on healthcare systems. The global digital health market, encompassing AI-driven solutions, is projected to reach hundreds of billions of dollars in the coming years. Aisel Health's focus on a specific, underserved niche within this market positions it to capture significant value. The company also stresses its commitment to data security, assuring that patient data is processed and stored within Europe, adhering strictly to GDPR and local regulations, and is never used for AI model training.

Carolin Gabor, Managing Partner and GP at Caesar Ventures, expressed strong confidence in the founding team and the company's vision: "Few problems in healthcare are as large or as overlooked as psychiatry’s, and few founders are as passionate about solving it the way Augusta and Christian are. We’re proud to lead this round, and look forward to supporting them to deliver the next generation of technology for psychiatry."

With this new capital, Aisel Health intends to expand its clinical and engineering teams and initiate its market entry into the United Kingdom, building on an existing commercial pipeline in private psychiatry. This strategic move precedes a planned larger Seed funding round, indicating ambitious growth objectives for the innovative HealthTech firm.